TINAVI Medical Technologies Co., Ltd. (688277.SS)
CNY 11.89
(0.93%)
CNY 11.89
(0.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 381.95 Million CNY | 31.99% |
| 2022 | 289.38 Million CNY | 36.84% |
| 2021 | 211.48 Million CNY | 128.07% |
| 2020 | 92.72 Million CNY | -20.92% |
| 2019 | 117.25 Million CNY | 14.91% |
| 2018 | 102.04 Million CNY | -77.49% |
| 2017 | 453.25 Million CNY | 822.09% |
| 2016 | 49.15 Million CNY | 515.93% |
| 2015 | 7.98 Million CNY | -43.98% |
| 2014 | 14.24 Million CNY | 21.14% |
| 2013 | 11.76 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 322.31 Million CNY | -4.65% |
| 2024 Q1 | 349.72 Million CNY | -8.44% |
| 2024 Q2 | 338.01 Million CNY | -3.35% |
| 2023 Q4 | 381.95 Million CNY | 21.92% |
| 2023 FY | 381.95 Million CNY | 31.99% |
| 2023 Q3 | 313.29 Million CNY | -2.8% |
| 2023 Q2 | 322.3 Million CNY | 104.61% |
| 2023 Q1 | 157.52 Million CNY | -45.57% |
| 2022 Q2 | 206.47 Million CNY | 1.15% |
| 2022 FY | 289.38 Million CNY | 36.84% |
| 2022 Q1 | 204.13 Million CNY | -3.47% |
| 2022 Q4 | 289.38 Million CNY | 26.02% |
| 2022 Q3 | 229.64 Million CNY | 11.22% |
| 2021 Q1 | 186.82 Million CNY | 101.47% |
| 2021 FY | 211.48 Million CNY | 128.07% |
| 2021 Q3 | 168.28 Million CNY | 0.13% |
| 2021 Q4 | 211.48 Million CNY | 25.67% |
| 2021 Q2 | 168.06 Million CNY | -10.04% |
| 2020 Q1 | 85.65 Million CNY | -26.95% |
| 2020 FY | 92.72 Million CNY | -20.92% |
| 2020 Q2 | 94.11 Million CNY | 9.87% |
| 2020 Q4 | 92.72 Million CNY | 24.5% |
| 2020 Q3 | 74.48 Million CNY | -20.86% |
| 2019 Q2 | 122.58 Million CNY | 0.0% |
| 2019 Q4 | 117.25 Million CNY | 0.0% |
| 2019 FY | 117.25 Million CNY | 14.91% |
| 2018 FY | 102.04 Million CNY | -77.49% |
| 2018 Q1 | 443.47 Million CNY | 2.26% |
| 2018 Q2 | 443.47 Million CNY | 0.0% |
| 2017 Q3 | 433.66 Million CNY | 1834.38% |
| 2017 Q4 | 433.66 Million CNY | 0.0% |
| 2017 FY | 453.25 Million CNY | 822.09% |
| 2017 Q2 | 22.41 Million CNY | 0.0% |
| 2017 Q1 | 22.41 Million CNY | 63.94% |
| 2016 Q2 | 5.07 Million CNY | 0.0% |
| 2016 Q4 | 13.67 Million CNY | -34.42% |
| 2016 FY | 49.15 Million CNY | 515.93% |
| 2016 Q1 | 5.07 Million CNY | -46.2% |
| 2016 Q3 | 20.85 Million CNY | 310.73% |
| 2015 Q3 | 7.98 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 9.43 Million CNY | 18.24% |
| 2015 FY | 7.98 Million CNY | -43.98% |
| 2014 FY | 14.24 Million CNY | 21.14% |
| 2013 FY | 11.76 Million CNY | 0.0% |